Our Mission
Improving outcomes in peripheral vascular interventions by safely delivering targeted therapeutic agents, locally instead of systemically, and directly to the anatomy where they are needed most.Our Mission
Improving outcomes in peripheral vascular interventions by safely delivering targeted therapeutic agents, locally instead of systemically, and directly to the anatomy where they are needed most.
Our Mission
Improving outcomes in peripheral vascular interventions by safely delivering targeted therapeutic agents, locally instead of systemically, and directly to the anatomy where they are needed most.
Overview
Mercator MedSystems, Inc. (“Mercator”, or the “Company”) is a medical device company focused on the clinical and commercial development of FDA cleared and CE marked, catheter-based, Micro-infusion technologies, including the Bullfrog® Micro-Infusion Device for the local delivery of pharmacologics and biologics to the peripheral vasculature. The Company has clinical studies underway in Deep Vein Thrombosis (DVT) and Below the Knee (BTK) Peripheral Arterial Disease (PAD). Mercator’s platform technology lends itself to the additional targeted delivery of therapeutics and regenerative biologics for coronary and peripheral cardiovascular applications and for denervation in hypertension.
Management Team
Trent Reutiman
CEO & Director
Mr. Reutiman has 25 years of commercial experience in the medical device field, including leadership positions in sales and marketing, and sales management. He has significant expertise in commercializing products for minimally invasive interventional procedures, and participated in the development of many new technologies. Reutiman worked at Webster, TX-based IDEV Technologies from April 2012 to March 2014. Prior to that, from November 2006 to January 2012, he was Vice President of Sales and Marketing at San Clemente, CA-based ROX Medical, Inc. From March 2000 to December 2005 he was Vice President of Sales and Marketing at Mountain View, CA-based RITA Medical Systems. Before that Reutiman held sales management and representation positions at Guidant Corporation and Cordis Corporation. Reutiman has a bachelor of science degree in business from Colorado State University and an MBA from UC Irvine’s Paul Merage School of Business.
Kirk P. Seward, Ph.D.
Co-Founder, President, Chief Science and Technology Officer
Dr. Seward has over 20 years of experience in the medical device field. He is the inventor of the Mercator Micro-Infusion Catheter and led its development from prototype through FDA 510(k) marketing clearance and clinical development. Prior to co-founding Mercator MedSystems Dr. Seward was a staff principal investigator at Lawrence Livermore National Laboratory. He completed his doctoral studies in mechanical engineering at the University of California at Berkeley, and his masters and bachelors in mechanical engineering at MIT. He has authored more than 50 patent applications.
Steve Baker
Chief Financial Officer
Mr. Baker has over 25 years of experience as CFO of public and private companies in the medical device, biotech, software, SaaS, telecom and hardware industries. Since 2014 he has been CFO at Mercator MedSystems. He has significant expertise in building and leading organizations through rapid growth, fundraising and optimizing financial performance. Baker has held CFO and senior financial positions with FrontRange Solutions, PeopleSoft, Novell, Roamware, Geoworks, Octel Communications and AT&T. Baker has a bachelor of arts degree in molecular biology from University of Pennsylvania and an MBA from Columbia University Graduate School of Business.
